SOX2-RELATED MICRORNAS AS PROGNOSTIC MARKERS OF RECURRENCE IN SURGICALLY TREATED NON-SMALL-CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Navarro, Alfons [1 ]
Campayo, Marc [2 ]
Vinolas, Nuria [2 ]
Ciria, Victor [1 ]
Diaz, Tania [1 ]
Marrades, Ramon [2 ]
Ramirez, Jose [2 ]
Gimferrer, Jose M. [2 ]
Monzo, Mariano [1 ]
Molins, Laureano [2 ]
机构：
[1] Univ Barcelona, E-08007 Barcelona, Spain
[2] Hosp Clin Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
miR-367; NSCLC; miR-145; SOX2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1062 / S1062
页数：1
相关论文
共 50 条
  • [21] Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer
    Marjanski, Tomasz
    Badocha, Michal
    Wnuk, Damian
    Dziedzic, Robert
    Ostrowski, Marcin
    Sawicka, Wioletta
    Rzyman, Witold
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 28 (03) : 368 - 374
  • [22] Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
    Rogado, J.
    Fenor De La Maza, M. D.
    Pacheco-Barcia, V.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Ballesteros, A.
    Mondejar, R.
    Donnay, O.
    Obispo, B.
    Colomer, R.
    Sanchez-Torres, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2107 - S2108
  • [23] Cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Pirker, Robert
    LUNG CANCER, 2012, 77 : S13 - S14
  • [24] Immunoistochemical detection of biological markers in women affected by non-small-cell lung cancer (NSCLC)
    Bencardino, Katia
    Mariucci, Sara
    Manzoni, Mariangela
    Morbini, Patrizia
    Rovati, Bianca
    Chatzileontiadou, Sofia
    Delfanti, Sara
    Nascimbene, Catarina
    Pozzi, Ernesto
    Danova, Marco
    ANNALS OF ONCOLOGY, 2007, 18 : 183 - 183
  • [25] Immune Cell Profiles as Predictors of Survival in Surgically Treated Non-Small Cell Lung Cancer (NSCLC)
    Sellmer, L.
    Kovacs, J.
    Neumann, J.
    Walter, J.
    Kauffmann-Guerrero, D.
    Syunyaeva, Z.
    Fertmann, J.
    Schneider, C.
    Zimmermann, J.
    Behr, J.
    Tufman, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S910 - S910
  • [26] Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer
    Fernandes, OJCB
    Almgren, SO
    Thaning, L
    Filbey, D
    Helsing, M
    Karlsson, M
    Magnusson, A
    Souza, D
    ACTA ONCOLOGICA, 2003, 42 (04) : 338 - 341
  • [27] Prognostic significance of Ki67, CD44,and CD 105 tumour markers in surgically treated non-small cell lung cancer (NSCLC)
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 382 - 382
  • [28] The significance of ERβ expression in surgically treated non-small-cell lung cancers
    Yung-Chie, L
    LUNG CANCER, 2005, 49 : S299 - S300
  • [29] TUMOR VOLUME IS A PROGNOSTIC FACTOR IN NON-SMALL-CELL LUNG CANCER TREATED WITH CHEMORADIOTHERAPY
    Alexander, Brian M.
    Othus, Megan
    Caglar, Hale B.
    Allen, Aaron M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1381 - 1387
  • [30] CpG island methylation of microRNAs is associated with tumor size and recurrence of non-small-cell lung cancer
    Kitano, Kentaro
    Watanabe, Kousuke
    Emoto, Noriko
    Kage, Hidenori
    Hamano, Emi
    Nagase, Takahide
    Sano, Atsushi
    Murakawa, Tomohiro
    Nakajima, Jun
    Goto, Akiteru
    Fukayama, Masashi
    Yatomi, Yutaka
    Ohishi, Nobuya
    Takai, Daiya
    CANCER SCIENCE, 2011, 102 (12) : 2126 - 2131
12345